05.08.2011 • News • Huntsman • Q2 2011 • sales and profits

Huntsman Q2 Adjusted Profit Up

Huntsman posted second-quarter net income attributable to the company of $114 million or $0.47 per share, flat with last year. Adjusted net income for the second quarter rose to $117 million or $0.48 per share from $75 million or $0.31 per share in the year-ago quarter.

Analysts polled by Thomson Reuters expected the company to earn $0.49 per share in the quarter. Analysts' estimates typically exclude special items.

Revenues were $2.93 billion versus $2.34 billion last year. The Street estimated revenues of $2.77 billion for the quarter.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature